SCHEMBL28030639

SCHEMBL28030639

Cc1c(C(=O)O)cc(Cl)c(O)c1C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP4 P27487 1/20 0.53
AKR1C2 P52895 8/20 0.50
AKR1C1 Q04828 8/20 0.50
AKR1C4 P17516 1/20 0.50
AKR1C3 P42330 1/20 0.50
TTR P02766 2/20 0.45
ALDH1A1 P00352 4/20 0.44
KDM4E B2RXH2 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
HSD17B10 Q99714 2/20 0.44
MAPT P10636 1/20 0.44
PKM P14618 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
LDHA P00338 2/20 0.42
LDHB P07195 2/20 0.42
TDP1 Q9NUW8 1/20 0.40
ACLY P53396 1/20 0.39
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27558948 0.84 MEN1 (0.42) DPP4AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL2787863 0.84 DPP4 (0.57) DPP4AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL23823369 0.84 AKR1C2 (0.53) AKR1C2AKR1C1AKR1C4AKR1C3TTR
SCHEMBL691741 0.82 AKR1C2 (0.52) AKR1C2AKR1C1AKR1C4AKR1C3TTR
SCHEMBL27916176 0.82 MEN1 (0.41) DPP4AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL5318766 0.82 AKR1C2 (0.61) DPP4AKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL8467731 0.80 MYC (0.43) AKR1C2AKR1C1AKR1C4AKR1C3ALDH1A1
SCHEMBL5961110 0.80 AKR1C2 (0.59) AKR1C2AKR1C1AKR1C4AKR1C3TTR
SCHEMBL10785106 0.80 LDHA (0.48) ALDH1A1KDM4EMEN1KMT2AHSD17B10
SCHEMBL27534718 0.80 LDHA (0.44) DPP4ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102341379-B Benzothiazine derivative, its preparation method and the application as medicine thereof PIERRE FABRE MEDICAMENT (FR) 2015-08-26 CN disclosed